calendar
8,093 catalysts · 5,443 phase readout · 2,304 8k filing · 343 pdufa · 259 earnings · 2 approval · 1 adcom
next 91 dayslessmore
MonWedFri
8,093 catalysts · 5,443 phase readout · 2,304 8k filing · 343 pdufa · 259 earnings · 2 approval · 1 adcom
Items: 9.01
Items: 5.02
Items: 1.05
Items: 3.01
Items: 3.01
Items: 5.07
Items: 3.01
Items: 9.01
Items: 3.01
Items: 3.03, 5.03, 9.01
Items: 3.01
Items: 1.02, 9.01
Items: 1.01, 3.02, 5.03, 7.01, 8.01, 9.01
Items: 5.02
Items: 3.02, 7.01, 9.01
Items: 1.01, 2.03
Items: 3.01
Items: 1.01, 3.02, 9.01
Items: 3.02, 3.03, 5.03, 9.01
Items: 5.07, 9.01
Items: 2.02, 9.01
Items: 1.01, 3.02, 7.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 2.02, 9.01
Items: 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 1.01, 2.03, 3.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 1.01, 7.01, 9.01
Items: 7.01, 9.01
Items: 2.02, 9.01
Items: 1.01, 9.01
Items: 1.01, 5.02, 8.01, 9.01
Items: 2.02, 9.01
Items: 7.01, 8.01, 9.01
Items: 2.02, 9.01
Items: 7.01, 9.01
Items: 7.01, 9.01
Items: 8.01
Items: 7.01, 9.01
Items: 7.01, 9.01
Items: 8.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 8.01
Items: 8.01
action date of January 4, 2027
action date of Jan. 21, 2027
Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL